Answer
The intravenous formulation is licensed for children with malignant hyperthermia. Oral licensing applies only to children meeting the product's stated age and weight criteria.
Sources for this answer
- Dantrium 100 mg Capsules — Current selected SmPCemc · Summary of Product Characteristics
- Dantrium IV 20mg — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.